Tolvaptan Increases Serum Sodium in Pediatric Patients With Heart Failure

2013 ◽  
Vol 34 (6) ◽  
pp. 1463-1468 ◽  
Author(s):  
Rebecca B. Regen ◽  
Ashley Gonzalez ◽  
Kasey Zawodniak ◽  
David Leonard ◽  
Raymond Quigley ◽  
...  
2013 ◽  
Vol 19 (10) ◽  
pp. S160
Author(s):  
Masatake Kobayashi ◽  
Kunihiko Teraoka ◽  
Yoichi Iwasaki ◽  
Yuto Kumai ◽  
Mamoru Aiga ◽  
...  

2017 ◽  
Vol 7 ◽  
pp. 27 ◽  
Author(s):  
Paggie P C Kim ◽  
Benjamin W Nasman ◽  
Erica L Kinne ◽  
Udochukwu E Oyoyo ◽  
Daniel K Kido ◽  
...  

Objectives: This study was undertaken to estimate the incidence and burden of cerebral microhemorrhage (CM) in patients with heart disease who underwent cardiopulmonary bypass (CPB), as detected on susceptibility-weighted imaging (SWI), a magnetic resonance (MR) sequence that is highly sensitive to hemorrhagic products. Materials and Methods: With Institutional Review Board waiver of consent, MR imaging (MRI) of a cohort of 86 consecutive pediatric patients with heart failure who underwent heart transplantation evaluation were retrospectively reviewed for CM. A nested case–control study was performed. The CPB group consisted of 23 pediatric patients with heart failure from various cardiac conditions who underwent CPB. The control group was comprised of 13 pediatric patients with similar cardiac conditions, but without CPB history. Ten patients in the CPB group were female (age: 5 days to 16 years at the time of the CPB and 6 days to 17 years at the time of the MRI). The time interval between the CPB and MRI ranged from 11 days to 4 years and 5 months. Six patients in the control group were female, age range of 2 days to 6 years old. The number of CM on SWI was counted by three radiologists (PK, EK and DK). The differences in number of CM between groups were tested for significance using Mann–Whitney U-test, α = 0.05. Using the univariate analysis of variance model, the differences in number of CM between groups were also tested with adjustment for age at MRI. Results: There are statistically significant differences in CM on SWI between the CPB group and control group with more CM were observed in the CPB group without and with adjustment for age at MRI (P < 0.001). Conclusions: Exposure of CPB is associated with increased prevalence and burden of CM among pediatric patients with heart failure.


2017 ◽  
Vol 120 (11) ◽  
pp. 2049-2055 ◽  
Author(s):  
David Higgins ◽  
Jessica Otero ◽  
Christa Jefferis Kirk ◽  
Jennifer Pak ◽  
Neal Jorgensen ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Muhammad Faisal ◽  
Willi Cawello ◽  
Stephanie Laeer ◽  

Purpose: Enalapril has an established safety and efficacy in adults and is used in hypertension, heart failure, and renal failure. In pediatric patients, enalapril is labeled for children with hypertension and used off label in children with heart failure. The systematic literature search aims to assess the current knowledge about enalapril and its active metabolite enalaprilat pharmacokinetics in children as a basis for dose delineation for pediatric patients with heart failure.Methods: A systematic literature review was performed in the PubMed database using relevant keywords. Dose normalization of relevant pharmacokinetic parameters of the identified studies was done for comparison between different diseases and pediatric age groups.Results: The literature search has resulted in three pediatric pharmacokinetic studies of enalapril out of which Wells et al. reported about children with hypertension and Nakamura et al., and Llyod et al. presented data for pediatric heart failure patients. The area under the curve values of enalaprilat in hypertensive pediatric patients increased with respect to the age groups and showed maturation of body functions with increasing age. Dose normalized comparison with the heart failure studies revealed that although the pediatric heart failure patients of &gt; 20 days of age showed the area under the curve a similar to that of hypertensive patients, two pediatric patients of very early age (&lt;20 days) were presented with 5–6-fold higher area under the curve values.Conclusion: Data related to the pharmacokinetics of enalapril and enalaprilat in hypertensive patients and few data for young heart failure children are available. Comparison of dose normalized exposition of the active metabolite enalaprilat indicated similarities between heart failure and hypertensive patients and a potentially high exposition of premature patients but substantially more pharmacokinetic studies are required to have reliable and robust enalapril as well as enalaprilat exposures especially in pediatric patients with heart failure as a basis for any dose delineation.


ASAIO Journal ◽  
2019 ◽  
Vol 65 (2) ◽  
pp. 106-116 ◽  
Author(s):  
Steven G. Chopski ◽  
Nohra M. Murad ◽  
Carson S. Fox ◽  
Randy M. Stevens ◽  
Amy L. Throckmorton

2012 ◽  
Vol 34 (2) ◽  
pp. 431-437 ◽  
Author(s):  
JonDavid Menteer ◽  
Virginia N. Beas ◽  
Jennifer C. Chang ◽  
Karen Reed ◽  
Jeffrey I. Gold

1999 ◽  
Vol 23 (11) ◽  
pp. 1001-1005 ◽  
Author(s):  
Manfred Marx ◽  
Ulrike Salzer-Muhar ◽  
Maria Wimmer

2018 ◽  
Vol 315 (4) ◽  
pp. H1051-H1062 ◽  
Author(s):  
Kathleen C. Woulfe ◽  
Cortney E. Wilson ◽  
Shane Nau ◽  
Sarah Chau ◽  
Elisabeth K. Phillips ◽  
...  

Sudden cardiac death from ventricular arrhythmias is more common in adult patients with with heart failure compared with pediatric patients with heart failure. We identified age-specific differences in arrhythmogenesis using a guinea pig model of acute β-adrenergic stimulation. Young and adult guinea pigs were exposed to the β-adrenergic agonist isoproterenol (ISO; 0.7 mg/kg) for 30 min in the absence or presence of flecainide (20 mg/kg), an antiarrhythmic that blocks Na+ and ryanodine channels. Implanted cardiac monitors (Reveal LINQ, Medtronic) were used to monitor heart rhythm. Alterations in phosphorylation and oxidation of ryanodine receptor 2 (RyR2) were measured in left ventricular tissue. There were age-specific differences in arrhythmogenesis and sudden death associated with acute β-adrenergic stimulation in guinea pigs. Young and adult guinea pigs developed arrhythmias in response to ISO; however, adult animals developed significantly more premature ventricular contractions and experienced higher arrhythmia-related mortality than young guinea pigs treated with ISO. Although there were no significant differences in the phosphorylation of left ventricular RyR2 between young and adult guinea pigs, adult guinea pigs exposed to acute ISO had significantly more oxidation of RyR2. Flecainide treatment significantly improved survival and decreased the number of premature ventricular contractions in young and adult animals in association with lower RyR2 oxidation. Adult guinea pigs had a greater propensity to develop arrhythmias and suffer sudden death than young guinea pigs when acutely exposed to ISO. This was associated with higher oxidation of RyR2. The incidence of sudden death can be rescued with flecainide treatment, which decreases RyR2 oxidation. NEW & NOTEWORTHY Clinically, adult patients with heart failure are more likely to develop arrhythmias and sudden death than pediatric patients with heart failure. In the present study, older guinea pigs also showed a greater propensity to arrhythmias and sudden death than young guinea pigs when acutely exposed to isoproterenol. Although there are well-described age-related cardiac structural changes that predispose patients to arrhythmogenesis, the present data suggest contributions from dynamic changes in cellular signaling also play an important role in arrhythmogenesis.


Sign in / Sign up

Export Citation Format

Share Document